Matches in Nanopublications for { ?s ?p "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP894892.RAuJkexCQxo9Wl742p-4W2NVWuc_Efc6Xzch_PAVW7pLw130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP894892.RAuJkexCQxo9Wl742p-4W2NVWuc_Efc6Xzch_PAVW7pLw130_provenance.
- NP206305.RAaKnw02wl-AOPUykMdIvDsVT70YckjfLpD35ibWY5m1M130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206305.RAaKnw02wl-AOPUykMdIvDsVT70YckjfLpD35ibWY5m1M130_provenance.
- NP723248.RADMjsSVJ8A7svdzYkrU9crALAo2L9VNmsOUxDcqdHWb8130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP723248.RADMjsSVJ8A7svdzYkrU9crALAo2L9VNmsOUxDcqdHWb8130_provenance.
- assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP315493.RAee_DF45ryG0USR0Y5Gi9kGxIWvKJwfWmeh3H69WQcwQ130_provenance.
- NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP522288.RAhM_K8qIpKNOkOoqN7Axp8prEutjZjQDzjQAA6T1APUU130_provenance.
- NP836487.RATU1N8lrnauFIHiiNhZHtvwlVKfzuolrb7u8bAxY4c2k130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836487.RATU1N8lrnauFIHiiNhZHtvwlVKfzuolrb7u8bAxY4c2k130_provenance.
- NP836486.RAF6a2MpnaBhHqGk4wfEKeJiZneBXncChSJIoOWSt2UyQ130_assertion description "[This study revealed the following characteristics of these disorders: 1) subjects with CLCNKB mutations showed one or more biochemical features of Gitelman syndrome (including hypomagnesemia, hypocalciuria, and fractional chloride excretion insensitivity to thiazide administration); and 2) subjects with KCNJ1 mutations appeared to show normal fractional chloride excretion sensitivity to furosemide and thiazide administration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP836486.RAF6a2MpnaBhHqGk4wfEKeJiZneBXncChSJIoOWSt2UyQ130_provenance.